Ms. Rosenberg’s experience covers the spectrum from early stage to Fortune 500 companies, including work in biopharmaceuticals, digital health, MedTech, and generics manufacturers. She has developed brand strategies and marketing plans for 10+ multibillion-dollar products in retail and hospital environments, from proof of concept through launch, commercialization, and lifecycle management. 

Ms. Rosenberg’s client work includes redesigning the commercial footprint of a biopharma marketing and sales model at two-thirds the cost without negative revenue impact; more than doubling market share for a lagging respiratory product; uncovering $200+ million in revenue opportunities in a generics portfolio for a top industry player; crafting strategies for mature brands portfolios and securing investment for implementation; and leading a business and cultural transformation for a mid-size pharmaceutical company that achieved $200 million in cost savings while sustaining key brand sales. 

Prior to joining A&M, Ms. Rosenberg has focused on scaling new ventures in healthcare and higher education, most recently finding product-market-fit and spearheading revenue generation for a Series-A health tech company. Previously, she was a Partner at McKinsey & Company in the North American Pharmaceuticals and Medical Devices Practice and a co-founder of the Digital Healthcare practice. 

Ms. Rosenberg earned a bachelor’s degree in economics from Barnard College at Columbia University, where she is currently an adjunct faculty member in economics, and a Ph.D. in economics from the University of Chicago. She is an angel investor in early-stage ventures in MedTech, biotech, and digital health.